Gastrodin promotes CNS myelination via a lncRNA Gm7237/miR-142a/MRF pathway

References

• Matas SL, Glehn F, Fernandes GB, et al. Cerebrospinal fluid analysis in the context of CNS demyelinating diseases. Arq Neuropsiquiatr. 2013;71(9B):685–688.
   PubMed Web of Science ®Google Scholar
• Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci. 2008;9:839–855.
   PubMed Web of Science ®Google Scholar
• Felts PA, Baker TA, Smith KJ. Conduction in segmentally demyelinated mammalian central axons. J Neurosci. 1997;17(19):7267–7277.
   PubMed Web of Science ®Google Scholar
• Patani R, Balaratnam M, Vora A, et al. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol Appl Neurobiol. 2007;33(3):277–287.
   PubMed Web of Science ®Google Scholar
• Patrikios P, Stadelmann C, Kutzelnigg A, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain. 2006;129:3165–3172.
   PubMed Web of Science ®Google Scholar
• Bercury KK, Macklin WB. Dynamics and mechanisms of CNS myelination. Dev Cell. 2015;32(4):447–458.
   PubMed Web of Science ®Google Scholar
• Cadavid D, Balcer L, Galetta S, et al. Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2017;16(3):189–199. .
   PubMed Web of Science ®Google Scholar
• Wang S, Bates J, Li X, et al. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell. 2013;12(2):252–264. .
   PubMed Web of Science ®Google Scholar
• Franklin RJM, Ffrench-Constant C. Regenerating CNS myelin - from mechanisms to experimental medicines. Nat Rev Neurosci. 2017;18(12):753–769.
   PubMed Web of Science ®Google Scholar
• Deshmukh VA, Tardif V, Lyssiotis CA, et al. A regenerative approach to the treatment of multiple sclerosis. Nature. 2013;502(7471):327–332. .
   PubMed Web of Science ®Google Scholar
• Najm FJ, Madhavan M, Zaremba A, et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature. 2015;522(7555):216–220. .
   PubMed Web of Science ®Google Scholar
• Mei F, Fancy SPJ, Shen YA, et al. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nat Med. 2014;20(8):954–960. .
   PubMed Web of Science ®Google Scholar
• Liu Y, Gao J, Peng M, et al. A review on central nervous system effects of gastrodin. Front Pharmacol. 2018;9:24/1-/18.
   Web of Science ®Google Scholar
• Xing Y, Li L. Gastrodin protects rat cardiomyocytes H9c2 from hypoxia-induced injury by up-regulation of microRNA-21. Int J Biochem Cell Biol. 2019;109:8–16.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang C, Yu B, et al. Gastrodin protects against ethanol-induced liver injury and apoptosis in HepG2 Cells and animal models of alcoholic liver disease. Biol Pharm Bull. 2018;41(5):670–679.
   PubMed Web of Science ®Google Scholar
• Lin LC, Chen YF, Lee WC, et al. Pharmacokinetics of gastrodin and its metabolite p-hydroxybenzyl alcohol in rat blood, brain and bile by microdialysis coupled to LC-MS/MS. J Pharm Biomed Anal. 2008;48(3):909–917.
   PubMed Web of Science ®Google Scholar
• Luo L, Kim S-W, Lee H-K, et al. Gastrodin exerts robust neuroprotection in the postischemic brain via its protective effect against Zn2+-toxicity and its anti-oxidative effects in astrocytes. Animal Cells Systems. 2018;22(6):429–437. .
   PubMed Web of Science ®Google Scholar
• Zhao X, Zou Y, Xu H, et al. Gastrodin protect primary cultured rat hippocampal neurons against amyloid-beta peptide-induced neurotoxicity via ERK1/2-Nrf2 pathway. Brain Res. 2012;1482:13–21.
   PubMed Web of Science ®Google Scholar
• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47–62.
   PubMed Web of Science ®Google Scholar
• Mattick JS, Taft RJ, Faulkner GJ. A global view of genomic information–moving beyond the gene and the master regulator. Trends Genet. 2010;26(1):21–28.
   PubMed Web of Science ®Google Scholar
• Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101–108. .
   PubMed Web of Science ®Google Scholar
• Wu T, Du Y. LncRNAs: from basic research to medical application. Int J Biol Sci. 2017;13(3):295–307.
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352.
   PubMed Web of Science ®Google Scholar
• Bartel DP. Metazoan MicroRNAs. Cell. 2018;173(1):20–51.
   PubMed Web of Science ®Google Scholar
• He D, Wang J, Lu Y, et al. lncRNA functional networks in oligodendrocytes reveal stage-specific myelination control by an lncOL1/Suz12 complex in the CNS. Neuron. 2017;93(2):362–378.
   PubMed Web of Science ®Google Scholar
• Lin ST, Heng MY, Ptacek LJ, et al. Regulation of myelination in the central nervous system by nuclear lamin B1 and non-coding RNAs. Transl Neurodegener. 2014;3(1):4.
   PubMedGoogle Scholar
• Steelman AJ, Thompson JP, Li J. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication. Neurosci Res. 2012;72(1):32–42.
   PubMed Web of Science ®Google Scholar
• Wahl SE, McLane LE, Bercury KK, et al. Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination. J Neurosci. 2014;34(13):4453–4465.
   PubMed Web of Science ®Google Scholar
• Song YX, Sun JX, Zhao JH, et al. Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion. Nat Commun. 2017;8:289.
   PubMed Web of Science ®Google Scholar
• Seo JS, Chua NH. Identification of long noncoding RNA-protein interactions through In Vitro RNA pull-down assay with plant nuclear extracts. Methods Mol Biol. 2019;1933:279–288.
   PubMedGoogle Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233.
   PubMed Web of Science ®Google Scholar
• Imig J, Brunschweiger A, Brummer A, et al. miR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction. Nat Chem Biol. 2015;11:107–114.
   PubMed Web of Science ®Google Scholar
• Liu J, Carmell MA, Rivas FV, et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science. 2004;305(5689):1437–1441.
   PubMed Web of Science ®Google Scholar
• Hutvagner G, Simard MJ. Argonaute proteins: key players in RNA silencing. Nat Rev Mol Cell Biol. 2008;9(1):22–32.
   PubMed Web of Science ®Google Scholar
• Emery B, Agalliu D, Cahoy JD, et al. Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell. 2009;138(1):172–185.
   PubMed Web of Science ®Google Scholar
• Koenning M, Jackson S, Hay CM, et al. Myelin gene regulatory factor is required for maintenance of myelin and mature oligodendrocyte identity in the adult CNS. J Neurosci. 2012;32(36):12528–12542.
   PubMed Web of Science ®Google Scholar
• Chinese Pharmacopoeia Commission. 2015. Beijing: Chinese Medical Science and Technology Press.
   Google Scholar
• Lu Y, Xu D. The study of EEG changes in epilepsy patients treated with gastrodin. Pharmac Clin Chin Mat Med. 2015;31:114.
   Google Scholar
• Chen L, Liu X, Wang H, et al. Gastrodin attenuates pentylenetetrazole-induced seizures by modulating the mitogen-activated protein kinase-associated inflammatory responses in mice. Neurosci Bull. 2017;33(3):264–272.
   PubMed Web of Science ®Google Scholar
• Wang XL, Xing GH, Hong B, et al. Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson’s disease: involvement of ERK1/2-Nrf2 signaling pathway. Life Sci. 2014;114:77–85.
   PubMed Web of Science ®Google Scholar
• Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010;9:775–789.
   PubMed Web of Science ®Google Scholar
• Li Y, Guo B, Yang R, et al. A novel long noncoding RNA lnc158 promotes the differentiation of mouse neural precursor cells into oligodendrocytes by targeting nuclear factor-IB. Neuroreport. 2018;29(13):1121–1128.
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discovery. 2017;16(3):203–222.
   PubMed Web of Science ®Google Scholar
• Lin S-T, Huang Y, Zhang L, et al. MicroRNA-23a promotes myelination in the central nervous system. Proc Natl Acad Sci U S A. 2013;110(43):17468–17473. S/1-S/11.
   PubMed Web of Science ®Google Scholar
• Lecca D, Marangon D, Coppolino GT, et al. MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis. Sci Rep. 2016;6(1):34503.
   PubMedGoogle Scholar
• Fan H-B, Liu Y-J, Wang L, et al. miR-142-3p acts as an essential modulator of neutrophil development in zebrafish. Blood. 2014;124(8):1320–1330.
   PubMed Web of Science ®Google Scholar
• Lalwani MK, Sharma M, Singh AR, et al. Reverse genetics screen in zebrafish identifies a role of miR-142a-3p in vascular development and integrity. PLoS One. 2012;7(12):e52588.
   PubMed Web of Science ®Google Scholar
• Talebi F, Ghorbani S, Chan WF, et al. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis. J Neuroinflammation. 2017;14(1): 55/1-/14. doi:10.1186/s12974-017-0832-7.
   PubMedGoogle Scholar